Log In
BCIQ
Print this Print this
 

Rexista Oxycodone XR

  Manage Alerts
Collapse Summary General Information
Company Intellipharmaceutics International Inc.
DescriptionControlled-release, abuse-deterrent formulation of oral oxycodone
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation U.S. - Fast Track (Treat pain)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/02/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today